
    accrual factor
  
['hormone-resistant prostate cancer', 'metastatic malignant neoplasm in the bone', 'metastatic prostate carcinoma']
['fludeoxyglucose f-18', 'fluorine f 18 sodium fluoride']

        Inclusion Criteria:

          -  Provides written informed consent

          -  Diagnosed with mCRPC and painful bone metastases, referred for Xofigo (radium Ra 223
             dichloride)

          -  Able to remain still for duration of the imaging procedure (about one hour)

        Exclusion Criteria:

          -  Metallic implants
      